Download Files:
Products Details
Product Description
– RET-IN-18 is a pyridone compound. is a potent inhibitor of RET. RET-IN-18 is a potent inhibitor of RET. RET-IN-18 has the potential for the research of diseases related to irritable bowel syndrome (IBS) and other gastrointestinal disorders, as well as cancers, and neurodegenerative diseases (extracted from patent WO2022017524A1, compound 1)[1].
Web ID
– HY-147564
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C26H28F6N4O4S
References
– [1]Huimin Chen, et al. Pyridone compound, preparation method therefor, and application thereof. Patent WO2022017524A1.
CAS Number
– 2759292-94-7
Molecular Weight
– 606.58
SMILES
– CCOC1=CC(NC=C1C2=CC=C(C(F)=C2)CC(NC3=CC(S(F)(F)(F)(F)F)=CC(C(NCCN(C)C)=O)=C3)=O)=O
Clinical Information
– No Development Reported
Research Area
– Cancer; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– RET
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
